Can an adult safely take Saphris (asenapine) together with Prozac (fluoxetine)?

Can You Be on Saphris and Prozac Together?

Yes, adults can generally take Saphris (asenapine) and Prozac (fluoxetine) together, but this combination requires careful monitoring for specific drug interactions and adverse effects, particularly QT prolongation and metabolic side effects.

Key Safety Considerations

QT Prolongation Risk

Both medications can prolong the QT interval, which is the primary concern with this combination:

• Saphris (asenapine) causes QT prolongation of 2-5 msec at therapeutic doses 1
• Prozac (fluoxetine) is an SSRI that can interact with drugs that prolong QT interval 2
• Combined use increases cumulative risk for cardiac arrhythmias, though serious events remain rare

Monitoring approach:

• Obtain baseline ECG before starting combination therapy
• Avoid this combination in patients with: history of cardiac arrhythmias, congenital long QT syndrome, bradycardia, or electrolyte abnormalities (hypokalemia, hypomagnesemia) 1
• Consider repeat ECG monitoring if doses are increased or if patient develops cardiac symptoms

Serotonin Syndrome Risk

While theoretically possible when combining an antipsychotic with an SSRI, the risk is relatively low with this specific combination. However, remain vigilant for symptoms including 2:

• Mental status changes (confusion, agitation)
• Neuromuscular hyperactivity (tremors, clonus, hyperreflexia, rigidity)
• Autonomic hyperactivity (hypertension, tachycardia, diaphoresis, diarrhea)

Symptoms typically emerge within 24-48 hours of combining medications or dose changes.

Clinical Context for This Combination

This combination is most commonly used in two scenarios:

1. Bipolar I Disorder with Comorbid Depression/Anxiety

• Saphris is FDA-approved for acute manic/mixed episodes in bipolar I disorder 1
• The combination of olanzapine and fluoxetine is specifically FDA-approved for bipolar depression 3
• While asenapine + fluoxetine lacks this specific approval, the rationale is similar for treating bipolar patients with persistent depressive symptoms

2. Schizophrenia with Comorbid Depression/Anxiety

• Saphris is approved for schizophrenia treatment 1
• SSRIs like Prozac may be added for comorbid depressive or anxiety symptoms

Metabolic and Other Adverse Effects

Weight gain and metabolic effects:

• Asenapine causes modest weight gain compared to other atypical antipsychotics like olanzapine 4, 5
• Fluoxetine is generally weight-neutral or may cause slight weight loss 6
• Combined metabolic risk is lower than with some other antipsychotic combinations

Common side effects to monitor:

• Somnolence (very common with asenapine: 15-23% vs 5-7% placebo) 1, 5
• Akathisia and extrapyramidal symptoms from asenapine 4
• Oral hypoesthesia/dysgeusia from sublingual asenapine 7
• SSRI-related effects: nausea, sexual dysfunction, activation 6

Practical Management Recommendations

Dosing considerations:

• Start with standard doses unless patient has specific risk factors
• Asenapine: typically 5-10 mg twice daily sublingually 1
• Fluoxetine: typically 20-60 mg daily (higher doses for OCD) 8
• No specific dose adjustments required for the combination itself

Important prescribing details for asenapine:

• Must be taken sublingually (extensive first-pass metabolism if swallowed) 7
• Patient must avoid eating or drinking for 10 minutes after administration 1
• Twice-daily dosing required

When to avoid this combination:

• Patients with baseline QTc >500 msec or history of Torsades de Pointes
• Concurrent use of other QT-prolonging medications (Class IA or III antiarrhythmics, certain antibiotics) 1
• Patients taking MAOIs (contraindicated with fluoxetine) 2

Medication Combination Rationale

The use of antipsychotic-antidepressant combinations has support in clinical practice, though guidelines emphasize the need for clear rationale 9. For bipolar disorder specifically, combining mood stabilizers or antipsychotics with antidepressants may be appropriate when the patient is adequately covered with mood-stabilizing medication to prevent manic switching 3.

Critical caveat: When using SSRIs in bipolar disorder, ensure adequate mood stabilization first, as antidepressants can precipitate manic episodes 3. The antipsychotic properties of asenapine provide some protection against this risk.